Home
Companies
Bayer
Clinical Trials

Clinical Trials Related to Bayer

Related studies linked through entity extraction aliases.

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

Status: COMPLETED
Phase: PHASE2

Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH

Status: COMPLETED
Phase: PHASE2

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

Status: COMPLETED
Phase: N/A

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

Status: COMPLETED
Phase: N/A

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Status: COMPLETED
Phase: PHASE1

Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent

Status: TERMINATED
Phase: PHASE3

Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation

Status: COMPLETED
Phase: NA

A Study of Regorafenib in Advanced Pancreatic Cancer Patients

Status: COMPLETED
Phase: PHASE2

Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy

Status: COMPLETED
Phase: PHASE4

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

Status: COMPLETED
Phase: PHASE4

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Status: COMPLETED
Phase: PHASE3

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Status: COMPLETED
Phase: PHASE3

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Status: COMPLETED
Phase: PHASE2

Essure (Model ESS310) Placement Rate Study

Status: COMPLETED
Phase: PHASE3

Cardiovascular Disease Risk Factors Prevalence Among Bayer's Employees in São Paulo, Brazil

Status: COMPLETED
Phase: N/A

Long-term Pre-dialysis Extension in Europe and Asia Pacific

Status: COMPLETED
Phase: PHASE2

A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

Status: COMPLETED
Phase: PHASE2

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

Status: COMPLETED
Phase: PHASE2

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Status: COMPLETED
Phase: PHASE2

Japanese BAY1000394 Monotherapy Phase I Study

Status: COMPLETED
Phase: PHASE1